18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

NCT05096234 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped loss of sponsor support

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: [ 18F]F-AraG PET

Sponsor

Stanford University

Collaborators

[object Object]